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Background 
 
Prevalence 
End Stage Renal Disease (ESRD) is rapidly becoming one of the largest growth areas 
in chronic health globally. ESRD is described as an irreversible loss of kidney 
function to the point that the kidneys fail to support life. When this occurs, Renal 
Replacement Therapy (RRT) (dialysis or transplantation) is required. Currently 1.4 
million patients are reported to be receiving RRT globally with the incidence of 
ESRD growing at approximately 8% annually. The growth of ESRD is reported at 
five times the rate of world population growth and not expected to level out in the 
near future. The forces behind this growth include the aging population, an increase in 
chronic disease burden, increasing life expectancies and increased access to RRT. In 
developed countries including Australia most patients with ESRD are offered RRT. 
Furthermore the burden of costs to meet the rising incidence and prevalence of ESRD 
is expected to increase substantially. In America for example, the direct cost of RRT 
is projected to reach $USD 28 billion by 2010. A large investment is therefore 
required to promote effective management and care interventions such as self care for 
people with ESRD (1, 2).  
 
Home and Satellite Haemodialysis  
Internationally haemodialysis in a hospital is reported as the most expensive modality 
with costs per person per year between USD 55,000 to 80,000 compared to home 
haemodialysis USD 33,000 to 50,000. It is also important to note that Australia and 
New Zealand have the highest proportion of patients in the world receiving home 
haemodialysis hence reducing some of the cost burden associated with ESRD in these 
countries. However worldwide there is only 0.5% of all haemodialysis patients 
receiving home haemodialysis compared to 1.2 million dialysis patients being treated 
in 20,000 haemodialysis centres (1).  
 
Home haemodialysis (HHD) requires self-management and is attended to 
predominately by the patient or their support person (3).  It is physiologically better as 
the patient is able to dialyse longer or more frequently (4), there is better psychosocial 
support and it offers patients more control over their lives, thus improving their 
quality of life (QoL) (5). Satellite haemodialysis (SHD) also involves some self-
management by the patients even though it is carried out in a hospital or community 
setting. As both HHD and SHD requires patients to be self managing, the patient, 
therefore recognised as the principle manager of their illness, enjoys increased 
autonomy over some aspects of their treatment, with less medical support provided(3).    
 
Self Management for ERSD 
Exploring self-management in ESRD is extremely important for patients as they 
encounter several challenges including ongoing symptoms, complex treatments and 
restrictions, uncertainty about life and a dependency on technology, all impacting 
upon their autonomy particularly after commencement of haemodialysis (2, 6). Self 
management is defined as “the patient’s positive efforts to oversee and participate in 
their health care in order to optimize health, prevent complications, control symptoms, 
marshal medical resources, and minimize the intrusion of the disease into their 
preferred lifestyles.” (7) p. 386) An important issue supporting self-management 
interventions for people with ESRD is the concept of adherence or compliance as it 
has been found that 33% to 50% of people are non adherent to their treatment. 
Furthermore several studies (quantitative and qualitative) have indicated that health 
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outcomes including adherence to treatment are much improved and costs reduced 
when patients are involved in managing their own chronic illness (2, 6).  
 
Interventions Promoting Self-management 
 
Self- Management Education 
While it is acknowledged that education about ESRD is given to patients during short 
clinical interactions, generally patients are left to make their own day to day decisions, 
hence self-management for these people is unavoidable (6). It is reported also that to 
best manage the complexities of psychological and behavioural issues intrinsic to 
people with ESRD, ongoing collaborative care and self-management education is 
required (2, 8). Current patient self-management education programs aim at achieving 
long-lasting changes in behaviour (9-13).  This intervention also improves patient 
adherence to their dialysis regime (including diet and fluid intake) (14-16) as 
unfortunately non-adherence to haemodialysis regimens can significantly impact on 
the patient’s quality of life and overall health to the point of serious long-term 
consequences and mortality (4, 14, 17).  
 
Psychosocial Support  
Many haemodialysis patients suffer from depression, anxiety, fear of their disease and 
the limitations and stress it puts on their lives (18). Reports indicate negative changes 
often occur in patients’ attitudes towards self-management of their haemodialysis. 
Patients can present as proud and autonomous in their ability to achieve self-care and 
then regress and stay passive in their treatment (19). In order to achieve self-
management of haemodialysis, the patient must take a more active role in their 
treatment which can be achieved through therapies that promote behavioural and 
lifestyle changes (12). Psychological support is currently recommended for patients 
undertaking self-management of their haemodialysis treatment (11). A number of 
different interventions are available, including behaviour modification and cognitive 
behavioural therapy (CBT) (11, 12). An individualised approach to such treatment is 
recommended (20) with patient’s responding positively from non-compliance, to 
being very empowered and self-managing (21).   
 
Patients with extensive social support systems have also shown improved adherence 
to treatment thus improving QoL and reducing risk of mortality (22, 23). For self-
managing patients to obtain optimal health outcomes, ongoing social support 
networks are required (22).  Kimmel defines social support as “the perception that an 
individual is a member of a complex network in which one can give and receive 
affection, aid, and obligation”(23)  p.1605). Family members, friends, pastors, 
acquaintances in the workplace, and medical personnel are all recognised as providers 
of social support and are important for the patient’s adjustment to chronic and acute 
illness (22-24).  
 
There are major benefits for patients who are self-managing their haemodialysis such 
as improved treatment adherence (14), QoL and physical wellbeing (25). However 
there is no current, clear or standard approach to practice, assisting and supporting 
patients towards self-management of haemodialysis. This systematic review will seek 
to establish best practice for the promotion of self-management of haemodialysis 
regimens for patients with end stage renal disease. 
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Objectives 
This systematic review seeks to establish what best practice is for: 
 
Interventions which promote self-management for patients with End Stage Renal 
Disease (ERSD) undergoing Haemodialysis.  
 
More specifically, the review questions are:  
 
1) Do education interventions improve self-management for patients with end stage 
renal disease? 
2) Do psychosocial interventions such as Cognitive Behavioural Therapy, 
behavioural therapy or other counselling therapies and social support, improve 
self-management for patients with end stage renal disease? 
 
Criteria for considering studies for this review 
 
Types of Studies 
This component of the review will consider randomised controlled trials (RCT’s) that 
compare support interventions such educational, psychological and psychosocial 
supports with a control group (receiving no treatment or the other supportive 
treatments listed above). 
 
In the absence of RCT’s other research designs, non-randomised controlled trials and 
before and after studies, will be considered for inclusion in a narrative summary to 
enable the identification of current best evidence regarding support interventions for 
those with ESRD.  
 
 
Types of participants 
 
This component of the review will consider studies with: 
 
• All adults over the age of 18 years  
• Patients with end stage renal disease  
• Undergoing haemodialysis  
 
 
Types of interventions/Phenomena of Interest 
All studies evaluating the following interventions will be considered for inclusion in 
the review such as: 
Interventions which promote self management including: 
• Education interventions.   
• Psychosocial interventions such as cognitive behavioural therapy and other 
behavioural therapies, counselling and social support. 
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Types of outcome measures/anticipated outcomes 
This component of the review will consider studies that include the following 
outcomes: 
• Adherence with haemodialysis treatment,  
• Depression and/or anxiety,  
• Quality of life,  
• Carer burnout,  
• Social support 
• Patient satisfaction 
• Adverse events potentially attributable to the intervention or control treatment 
• Cost effectiveness of home haemodialysis  
 
Search Strategy for identification of studies 
The review will consist of a search of published and unpublished literature in the 
English language. The following databases will be searched to identify keywords 
contained in the title and abstract and relevant MESH headings and descriptor terms. 
 
Cochrane Database of Systematic Reviews in the Cochrane Library 
Cochrane Central Register of Controlled (CENTRAL) in the Cochrane Library 
CINAHL 
Clinical Trial Databases 
Medline (1966 to present)  
EMBASE  
PsycINFO (1966 to May 2007) 
Web of Science 
 
Reference lists of published studies and reviews will be scrutinised. 
 
Individuals and organisations with an interest in ESRD and self-management research 
will be contacted to identify unpublished and ongoing studies relevant to the review 
 
Dissertation abstracts will be searched for unpublished studies. 
The search strategy will be limited to the following years 1966 to 2007. 
 
Key search terms are shown in table 1 (see appendix1). 
 
Methods of review 
 
Critical Appraisal 
Papers selected for retrieval will be assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using the standardised critical 
appraisal instruments for the Joanna Briggs Institute System for the Unified 
Management, Assessment and Review of Information package (SUMARI) (Appendix 
2).  The studies will be categorised according to the level of evidence presented. Any 
disagreements that arise between the reviewers will be resolved through discussion 
with a third reviewer.  
 
Data Extraction: 
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Data will be extracted from papers included in the review using standardised data 
extraction tools from the Joanna Briggs Institute System for the Unified Management, 
Assessment and Review of Information package (Appendix 3). 
 
Data Synthesis 
 
Where possible quantitative research study results will be pooled in statistical meta-
analysis using Review manager software from the Cochrane Collaboration (Review 
manager V4.04).  All results will be double entered.  Heterogeneity will be assessed 
using the standard Chi-square and visual interpretation of the graphs. Significant 
heterogeneity will be assigned when the p value is less than 0.05. The type of data 
collected will determine the type of analytical approach used during synthesis. For 
example odds ratio will be used to summarise effect for dichotomous data, and 
weighted mean differences (for continuous data) and their 95% confidence intervals 
will be calculated for analysis.  Where statistical pooling is not possible the findings 
will be presented in narrative form. 
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APPENDIX 1 
 
Search Strategy – Medline 
1 exp Kidney failure, chronic/ 
2 exp Renal failure 
3 end stage renal disease 
4 ESRD 
5 chronic kidney disease 
6 1 or 2 or 3 or 4 or 5 
7 exp Hemodialysis units, hospital/ 
8 exp Hemodialysis, home/ 
9 exp Renal replacement therapy/ 
10 haemodialysis 
11 RRT 
12 hemodialysis 
13 7 or 8 or 9 or 10 or 11 or 12 
14 exp Social support/ 
15 exp Cognitive therapy/ 
16 exp Patient education/ 
17 exp Counseling/ 
18 exp diet therapy/ 
19 quality of Life therapy 
20 nutrition 
21 psychoeducation 
22 counselling 
23 supportive therapy 
24 behavio*al therapy 
25 CBT 
26 psychosocial 
27 psychological intervention 
28 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 
29 exp Quality of life/ 
30 exp Self care/ 
31 exp Self efficacy/ 
32 health related quality of life 
33 self management  
34 29 or 30 or 31 or 32 or 33 
35 RANDOMIZED CONTROLLED TRIAL.pt. 
36 CONTROLLED CLINICAL TRIAL.pt. 
37 RANDOMIZED CONTROLLED TRIALS.sh. 
38 RANDOM ALLOCATION.sh. 
39 DOUBLE BLIND METHOD.sh. 
40 SINGLE BLIND METHOD.sh. 
41 or/35-40 
42 ANIMALS/ not HUMANS/ 
43 41 not 42 
44 CLINICAL TRIAL.pt. 
45 exp CLINICAL TRIALS/ 
46 (clin$ adj25 trial$).ti,ab. 
47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab. 
48 PLACEBOS.sh. 
49 placebo$.ti,ab. 
50 random$.ti,ab. 
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51 RESEARCH DESIGN.sh. 
52 or/44-51 
53 52 not 42 
54 COMPARATIVE STUDY.sh. 
55 exp EVALUATION STUDIES/ 
56 FOLLOW UP STUDIES.sh. 
57 PROSPECTIVE STUDIES.sh. 
58 (control$ or prospectiv$ or volunteer$).ti,ab. 
59 or/54-58 
60 59 not 42 
61 43 or 53 or 60 
62 6 and 13 and 28 and 34 
63 61 and 62 
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APPENDIX 2 
The Joanna Briggs Institute 
Critical Appraisal of Evidence of Effectiveness 
 
Reviewer________________________________________  Date________________ 
 
Author________________  Year__________ Record Number________ 
 
1. Was the assignment to treatment groups random? 
yes   no   not clear  NA  
 
2. Were participants blinded to treatment allocation? 
yes   no   not clear  NA  
 
3. Was allocation to treatment groups concealed from the allocatur? 
yes   no   not clear  NA  
 
4. Were the outcomes of people who withdrew described and included in the 
analysis? 
yes   no   not clear  NA  
 
5. Were those assessing the outcomes blind to the treatment allocation? 
yes   no   not clear  NA  
 
6. Were control and treatment groups comparable at entry? 
yes   no   not clear  NA  
 
7. Were groups treated identically other than for the named interventions? 
yes   no   not clear  NA  
 
8. Were outcomes measured in the same way for all groups? 
yes   no   not clear  NA  
 
9. Were outcomes measured in a reliable way? 
yes   no   not clear  NA  
 
10. Was there adequate follow-up of participants? (>80%) 
yes   no   not clear  NA  
 
11. Was appropriate statistical analysis used? 
yes   no   not clear  NA  
 
 
Overall appraisal: Include         Excluded     Seek further info  
 Comments (including reasons for exclusion): __________________________ 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
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APPENDIX 3 
Joanna Briggs Institute 
Data Extraction Form (Quantitative Data) 
 
Author  Record Number  
 
Journal  
 
Year  
 
Reviewer  
 
 
Method _________________________________________________________ 
 
Setting  _________________________________________________________ 
 
Participants _________________________________________________________ 
 
 
 
Number of Participants 
 
Group A  Group B  
 
Interventions 
 
Intervention A _________________________________________________________ 
  _________________________________________________________ 
  _________________________________________________________ 
 
Intervention B _________________________________________________________ 
  _________________________________________________________ 
  _________________________________________________________ 
 
Outcome Measures 
Outcome Description 
 
Scale/Measure 
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Results 
Dichotomous Data 
Outcome Treatment Group 
Number/total number 
Control Group 
Number/total number 
 
 
  
 
 
  
 
Continuous Data 
Outcome Treatment Group 
Mean & SD (number) 
Control Group 
Mean & SD (number) 
 
 
  
 
 
  
 
 
  
 
Authors Conclusion 
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________  
 
Reviewers Conclusion 
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
